How Citalopram hydrobromide is synthesized？

Citalopram hydrobromide is a medication that is commonly used in the treatment of depression and anxiety disorders. The drug is known as a selective serotonin reuptake inhibitor (SSRI), which means that it works by increasing the levels of serotonin in the brain. Serotonin is a neurotransmitter that is responsible for regulating mood, appetite, sleep, and other bodily functions. Citalopram hydrobromide is derived from the compound citalopram, which is a racemic mixture of two enantiomers (S)-citalopram and (R)-citalopram.

The synthesis of citalopram hydrobromide is a multistep process that involves several chemical reactions. The following is a detailed description of how citalopram hydrobromide is synthesized:

Step 1: Synthesis of (S)-citalopram

The first step in the synthesis of citalopram hydrobromide is the preparation of (S)-citalopram. This enantiomer is more active than its counterpart (R)-citalopram and is responsible for the therapeutic effects of the drug. The synthesis of (S)-citalopram involves the following steps:

1.1. Preparation of ethyl-3-amino-2-oxo-4-phenylbutanoate

The starting material for the synthesis of (S)-citalopram is ethyl-3-amino-2-oxo-4-phenylbutanoate. This compound is prepared by reacting ethyl-3-oxobutanoate with phenylhydrazine in the presence of an acid catalyst. The resulting product is a yellow crystalline solid that is used in the next step.

1.2. Preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride

The second step in the synthesis of (S)-citalopram involves the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride. This compound is prepared by reacting ethyl-3-amino-2-oxo-4-phenylbutanoate with (S)-2-(bromomethyl)-1,3-dioxolane in the presence of a base catalyst. The resulting product is a white crystalline solid that is further reacted with N-methylthiophthalimide in the presence of sodium hydride to yield (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine. This compound is then treated with hydrochloric acid to yield (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride.

1.3. Resolution of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride

The final step in the synthesis of (S)-citalopram involves the resolution of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride. This is done by reacting the compound with tartaric acid to yield two diastereoisomers, which are then separated using chromatography. The desired (S)-citalopram is obtained as a white crystalline solid with a high level of purity.

Step 2: Synthesis of citalopram hydrobromide

The second step in the synthesis of citalopram hydrobromide is the conversion of (S)-citalopram into citalopram hydrobromide. This is done by reacting (S)-citalopram with hydrobromic acid in the presence of an organic solvent such as isopropanol. The resulting product is a white crystalline solid that is purified by recrystallization. The final product is citalopram hydrobromide, which is used as the active ingredient in the medication.

In conclusion, the synthesis of citalopram hydrobromide is a complex process that involves several chemical reactions. The drug is derived from the compound citalopram, which is synthesized using ethyl-3-amino-2-oxo-4-phenylbutanoate as the starting material. The synthesis of (S)-citalopram involves several steps, including the preparation of ethyl-3-amino-2-oxo-4-phenylbutanoate, (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride, and the resolution of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride. The final step in the synthesis of citalopram hydrobromide involves the conversion of (S)-citalopram into citalopram hydrobromide using hydrobromic acid. The resulting product is a white crystalline solid that is used in the formulation of the medication.